ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 650289 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 650289; 2) Community: the network communities that were significantly associated with the response to NSC 650289; 3) Molecule: the relationships between components within communities and NSC 650289; 4) MDR: the compounds that were significantly associated with the NSC 650289.

NSC Compound Enrichment Correlation
NSC 729176 6,7-dimethyl-2-(thien-2-ylcarbonyl)-3-trifluoromethylquinoxa line 1,4-dioxide 0.0295480456086947 0.096752655
NSC 732188 Null 0.0295480456086947 -0.23532087
NSC 747460 Null 0.0295480456086947 -0.061096748
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0295480456086947 -0.068115026
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0295480456086947 0.28755708
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0295480456086947 -0.068415771
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0295480456086947 -0.019909177
NSC 87500 Solacongestidine 0.0295480456086947 -0.014050494
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0314734733353265 -0.071737674
NSC 374028 Camptothecin Derivative 0.0314734733353265 0.17094555
Total:61  Current:41    [First] [Prev] [Next] [Last]